Home LiteratureArticle Details
PMID: 3305362 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Activation of the classical and alternative pathways of complement by Treponema pallidum subsp. pallidum and Treponema vincentii.

Infection and immunity ·Vol. 55 ·No. 9 ·1987-09-00 ·Pages 2066-73

Fitzgerald TJ

Abstract

Both in vivo and in vitro studies have indicated that complement plays an important role in the syphilitic immune responses. Few quantitative data are available concerning activation of the classical pathway by Treponema pallidum subsp. pallidum, and no information is available on treponemal activation of the alternative pathway. Activation of both pathways was compared by using T. pallidum subsp. pallidum and the nonpathogen T. vincentii. With rabbit and human sources of complement, both organisms rapidly activated the classical pathway, as shown by hemolysis of sensitized sheep erythrocytes and by the generation of soluble C4a. With human sources of complement, both organisms also activated the alternative pathway, as shown by hemolysis of rabbit erythrocytes and by the generation of soluble C3a in the presence of magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA). During incubation, organisms remained actively mobile and did not lyse, indicating that activation was a function of complement reactivity with the intact outer treponemal surface. In addition, freshly harvested T. pallidum subsp. pallidum immediately activated both pathways of complement; preincubation of organisms did not enhance complement reactivity. T. vincentii was a more potent activator of this pathway. T. pallidum subsp. pallidum contained almost four times as much surface sialic acid as T. vincentii did. When sialic acid was enzymatically removed from T. pallidum subsp. pallidum, enhanced activation of the alternative pathway was detected. It is proposed that T. pallidum subsp. pallidum retards complement-mediated damage by the alternative pathway through surface-associated sialic acid. This may be an important virulence determinant that enables these organisms to readily disseminate through the bloodstream to infect other tissues.

MeSH Terms
Animals Complement Activation Complement Pathway, Alternative Complement Pathway, Classical Dose-Response Relationship, Immunologic Humans In Vitro Techniques Rabbits Sialic Acids/physiology Time Factors Treponema/immunology Treponema pallidum/immunology
Chemicals
Sialic Acids
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Fitzgerald T J
References (44)
44 references, click to expand
  1. C3 shunt activation in human serum chelated with EGTA.
    J Immunol. 1972 Oct;109(4):807-9 PMID: 4627510
  2. Activation of the alternate pathway of human complements by rabbit cells.
    J Immunol. 1974 Jul;113(1):348-58 PMID: 4134064
  3. Rabbit globulin and antiglobulin factors associated with Treponema pallidum growth in rabbits.
    Br J Vener Dis. 1974 Dec;50(6):421-7 PMID: 4614883
  4. Demonstration of extracellular material at the surface of pathogenic T. pallidum cells.
    Br J Vener Dis. 1976 Feb;52(1):1-8 PMID: 769911
  5. Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.
    J Immunol. 1976 Jul;117(1):197-207 PMID: 778262
  6. Scanning electron microscopy of Treponema pallidum (Nichols strain) attached to cultured mammalian cells.
    J Bacteriol. 1977 Jun;130(3):1333-44 PMID: 324985
  7. Characterization of the attachment of Treponema pallidum (Nichols strain) to cultured mammalian cells and the potential relationship of attachment to pathogenicity.
    Infect Immun. 1977 Nov;18(2):467-78 PMID: 336548
  8. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Proc Natl Acad Sci U S A. 1978 Apr;75(4):1971-5 PMID: 273923
  9. Studies on the fluorescent treponemal antibody (FTA) test.
    Br J Vener Dis. 1966 Mar;42(1):8-15 PMID: 5326076
  10. Lytic effect of trypsin, lysozyme, and complement on Treponema pallidum.
    Br J Vener Dis. 1968 Sep;44(3):193-200 PMID: 4972004
  11. Early syphilis: immunoglobulins reactive in immunofluorescence and other serologic tests.
    J Immunol. 1969 May;102(5):1250-9 PMID: 4976968
  12. Development of an experimental syphilis vaccine.
    Med Clin North Am. 1972 Sep;56(5):1217-20 PMID: 4559749
  13. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20 PMID: 276881
  14. Surface mucopolysaccharides of Treponema pallidum.
    Infect Immun. 1979 Apr;24(1):244-51 PMID: 156696
  15. Electron microscopy of treponemes subjected to the Treponema pallidum immobilization (TPI) test. II. Immunoelectron microscopy.
    Acta Pathol Microbiol Scand C. 1979 Aug;87C(4):263-8 PMID: 386711
  16. Surface-associated host proteins on virulent Treponema pallidum.
    Infect Immun. 1979 Dec;26(3):1048-56 PMID: 93574
  17. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    N Engl J Med. 1980 Jul 31;303(5):259-63 PMID: 6900901
  18. Sulfhydryl oxidation using procedures and experimental conditions commonly used for Treponema pallidum.
    Br J Vener Dis. 1980 Jun;56(3):129-36 PMID: 7000301
  19. Detection of circulating immune complexes in the sera of rabbits with experimental syphilis: possible role in immunoregulation.
    Infect Immun. 1980 Aug;29(2):575-82 PMID: 6452412
  20. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    J Exp Med. 1982 Mar 1;155(3):809-19 PMID: 6801180
  21. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    J Immunol. 1983 Feb;130(2):845-9 PMID: 6848598
  22. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.
    J Immunol. 1983 Sep;131(3):1443-51 PMID: 6411816
  23. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.
    Infect Immun. 1984 Feb;43(2):684-92 PMID: 6198283
  24. Further evidence for hyaluronidase activity of Treponema pallidum.
    Can J Microbiol. 1983 Nov;29(11):1507-13 PMID: 6423249
  25. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Anal Biochem. 1984 Jan;136(1):75-88 PMID: 6711816
  26. Cobra venom factor abrogates passive humoral resistance to syphilitic infection in hamsters.
    Infect Immun. 1984 Jun;44(3):740-2 PMID: 6724696
  27. Location of the inter-chain disulfide bonds of the third component of human complement.
    Biochem Biophys Res Commun. 1985 Feb 28;127(1):264-9 PMID: 3977921
  28. Detection and functional characterization of early appearing antibodies in rabbits with experimental syphilis.
    Can J Microbiol. 1985 Jan;31(1):62-7 PMID: 3886112
  29. Hyaluronic acid-complement interactions--I. Reversible heat-induced anticomplementary activity.
    Mol Immunol. 1985 Apr;22(4):391-7 PMID: 4033663
  30. Hyaluronic acid-complement interactions--II. Role of divalent cations and gelatin.
    Mol Immunol. 1985 Aug;22(8):843-8 PMID: 4047042
  31. Binding of glycosaminoglycans to the surface of Treponema pallidum and subsequent effects on complement interactions between antigen and antibody.
    Genitourin Med. 1985 Feb;61(1):13-20 PMID: 3936770
  32. Differences in susceptibility to infection with Treponema pallidum (Nichols) between five strains of guinea pig.
    Genitourin Med. 1985 Feb;61(1):21-6 PMID: 3910539
  33. Immune immobilization of Treponema pallidum: antibody and complement interactions revisited.
    Can J Microbiol. 1985 Dec;31(12):1147-51 PMID: 3913494
  34. Immobilization and neutralization of Treponema pallidum attached to cultured mammalian cells.
    Can J Microbiol. 1985 Dec;31(12):1152-6 PMID: 3913495
  35. Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense.
    Infect Immun. 1986 Apr;52(1):223-9 PMID: 3633873
  36. The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D.
    Infect Immun. 1986 May;52(2):579-85 PMID: 3699896
  37. Location of the interchain disulfide bonds of the fourth component of human complement (C4): evidence based on the liberation of fragments secondary to thiol-disulfide interchange reactions.
    J Immunol. 1986 Jun 1;136(11):4152-6 PMID: 3701066
  38. Role of circulating immune complexes in human secondary syphilis.
    J Infect Dis. 1986 Jun;153(6):1014-22 PMID: 3517185
  39. The effect of C3 depletion on resistance of hamsters to infection with the yaws spirochete.
    Sex Transm Dis. 1986 Oct-Dec;13(4):245-50 PMID: 3810383
  40. Kinetics of antibody response to polypeptides of pathogenic and nonpathogenic treponemes in experimental syphilis.
    Sex Transm Dis. 1986 Oct-Dec;13(4):251-7 PMID: 3544258
  41. Immune complexes in experimental syphilis: a methodologic evaluation.
    Sex Transm Dis. 1982 Oct-Dec;9(4):170-7 PMID: 6765562
  42. Study of the antigenic structure of Treponema pallidum by specific agglutination.
    Am J Hyg. 1957 Sep;66(2):160-72 PMID: 13458181
  43. Influence of lysozyme upon the treponeme immobilization reaction.
    Am J Hyg. 1961 Mar;73:236-44 PMID: 13769911
  44. Protective layer covering pathogenic treponemata.
    Lancet. 1963 Feb 23;1(7278):423-5 PMID: 14021145
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1987-09-00
Pages
2066-73
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC260658
Subset
IM
Grants
NIAID NIH HHS · AI 16585 · United States
NIAID NIH HHS · AI 18619 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]